多发性骨髓瘤中的表观遗传重编程 - - 挑战与机遇
Subhasree Kumar1, Lev M Kats1,2, Emily Gruber1
1Peter MacCallum Cancer Centre and the Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
International journal of cancer
|April 2, 2025
概括
表观遗传改变驱动癌症,提供了塑性适应机制. 了解多发性骨髓瘤中的这些变化是开发针对异常表观基因组的新疗法的关键.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
背景情况:
- 癌症的发展涉及遗传突变和表观遗传重编程.
- 表观遗传变化,与遗传突变不同,是塑性的,并允许快速的细胞适应.
- 多发性骨髓瘤表现出显著的遗传和表观遗传异质性,使治疗复杂化.
研究的目的:
- 审查多发性骨髓瘤中常见的表观遗传变化.
- 探索瘤发生过程中的遗传和表观遗传进化之间的相互作用.
- 讨论针对髓瘤表观基因组的新型治疗策略.
主要方法:
- 在多发性骨髓瘤中表观遗传变化的文献综述.
- 对癌症的遗传和非遗传进化机制的分析.
- 讨论新兴的表观遗传逆转策略.
主要成果:
- 表观遗传重编程是癌症的标志,有助于恶性性质.
- 染色素的可塑性促进癌细胞快速适应环境变化.
- 在多发性骨髓瘤中常见的表观遗传变化得到了广泛的描述.
结论:
- 了解表观遗传改变对于改善多发性骨髓瘤患者的治疗结果至关重要.
- 准异常表观基因组代表了对髓瘤的有希望的治疗途径.
- 遗传和表观遗传因素的相互作用推动了髓瘤的进展.
更多相关视频
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.3K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.6K
相关概念视频
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
Introduction to Nuclear Reprogramming
1.9K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
1.9K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
